SEC Form 4/A · accession 0000899243-16-028025
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Darren S Cline
Officer — EVP, Commercial
Period of report
Aug 25, 2015
Accepted (ET)
Aug 24, 2016 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option Right to BuyF2,F3 | $39.15 | Aug 25, 2015 | A | 2,220 | A | — | Aug 25, 2025 | Common Stock | 2,220 | 2,220 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Due to administrative error, on August 22, 2016, a Form 4 that had already been filed on August 25, 2015 was refiled (SEC Accession No. 0001203311-16-000118). This amendment to Form 4 is being filed solely to "withdraw" the mistakenly re-filed Form 4. One of the transactions reported in the August 22, 2016 Form 4 (an acquisition of 2,200 incentive stock options to purchase Common Stock) is being repeated in this amendment solely to be able to file this amendment with the SEC's EDGAR system. The Reporting Person's holdings as of the date of this Form 4/A filing are set forth in Table 1 above.
- F3The option shares shall vest at a rate of 25% on 08/25/2016 and monthly thereafter until all shares are fully vested four years from grant date.